Coronavirus Testing - October 7th, 2020
SARS-CoV-2 Testing Comparison Information (Updated)
Please review this document for the most recent SARS-CoV-2 Testing Sensitivity (PPA) and Specificity (NPA) information.
Regional Medical Laboratory continues to be a valuable leader at the forefront of the Coronavirus pandemic, having conducted more than 131,000 SARS-CoV-2 PCR tests over the last 4 months to meet the COVID-19 testing needs of the communities we serve.
We are conducting this testing 24x7, across 3 robust testing platforms (6 instruments) with the capacity to perform 2200 tests per day. We are currently providing SARS-COV-2 PCR results within 24 hours of the receipt of the specimen at the testing laboratory.
We are also pleased to announce that we have secured additional testing capacity and a 7th SARS-CoV-2 PCR testing instrument will be added to our central laboratory by early September. The additional instrument will increase our daily capacity from 2200 to 3100 tests per day.
We are committed to provisioning this much needed testing to the communities we serve as we partner with you to insure the health of our population. We will continue to increase our capacity and source supplies to meet the demand as a trusted partner in the fight against the pandemic.
Click Here for comprehensive updates and links for Coronavirus (SARS-CoV-2/COVID-19) as this page is updated frequently.
Pre-authorization for Genetic and Molecular testing
Providing the best possible care to you and your patients is always the number one priority with Regional Medical Laboratory (RML). Many insurance companies are now requiring pre-authorization for genetic and molecular testing. Payers will only cover testing when used for certain diagnostic conditions. The payer may not cover the testing if it is done as a screening. RML is encouraging all our clients to check with the patient’s insurance before ordering genetic and molecular tests, to determine if pre-authorization is needed.
October 20, 2011: BCBSOK announces Regional Medical Laboratory, Inc., as one of its preferred laboratories
Effective November 1, 2011, Blue Cross and Blue Shield of Oklahoma (BCBSOK) has selected Regional Medical Laboratory, Inc. (RML) as one of its preferred outpatient clinical reference laboratories. RML will be one of the preferred statewide providers for outpatient clinical laboratory services for BCBSOK. RML has multiple locations statewide, full-time pathologists on staff and convenient technology that provides access to prompt lab results.
Learn more about RML's preferred status with Blue Cross and Blue Shield of Oklahoma read more in the RML Billing Section.
Regional Medical Laboratory is a nationally-renowned commercial pathology laboratory that provides testing services for thousands of physicians and hospitals within a four-state region. Regional Medical Laboratory offers many specialized testing services. Some of these special tests need to be scheduled with our laboratory in advance; that information is listed within each of those tests in the Test Directory for patient and scheduling information. RML and PLA offer a variety of flexible and unique services. From having pathologists on site and on call to computer interfacing solutions, service is what our customers can rely on for the laboratory needs of their patients and practice.